Hospital Trends: The Formulary Audit

The industry’s largest, most comprehensive, and detailed audit of hospital formulary decisions and trends.

Download our brochure for more information.

Overview

For almost 30 years, HRA has longitudinally tracked formulary uptake, formulary status, and restrictions in the hospital setting across a number of key categories via its Medical Trends in Hospital Formularies data set, providing pharmaceutical clients with valuable data unavailable anywhere else. 
 
In 2012, HRA has re-engineered this valuable tracking tool to create a new offering, Hospital Trends: The Formulary Audit.  HRA’s syndicated formulary tracker covers 15 key hospital-relevant therapeutic categories across major U.S. hospitals and hospital systems.

Key Objectives

Hospital Trends: The Hospital Formulary Audit tracks key products across relevant categories on the following metrics:

• On formulary, unrestricted
• On formulary, restricted (including the restrictions that apply)
• Non-formulary, not stocked
• Non-formulary, stocked
• Timing of last P&T review for the category

Sample

Pharmacy Directors from 300 unique acute care hospitals within the United States

• Directors of Pharmacy involved in P&T Committee decisions
• Mix of stand-alone hospitals, hospitals from highly-integrated/highly-controlled systems and hospitals from loosely-integrated/loosely-controlled systems
  • Targeting approximately 40% of sample from stand-alone hospitals and 60% from systems; sample stratification and weighting based on these parameters
• Includes range of hospital sizes, regions, academic affiliations 

Who Should Purchase?

Manufacturers of inline or pipeline pharmaceutical agents marketed or used in the hospital setting.

Applications

This research will enable pharmaceutical manufacturers to:

• Track formulary uptake and formulary presence of their products and those of competitors
• Diagnose challenges to formulary positioning by region, hospital size, or system influence
• Provide strategic sales direction in cases where formulary presence is lacking or restrictions are prominent

Method

Self-administered Internet-based survey, conducted nine times per year

Each category queried three times per year:

JANUARY/FEBRUARY		MAY		SEPTEMBER
Antibiotics		Antibiotics		Antibiotics
Antivirals		Antivirals		Antivirals
IvIG		IvIG		IvIG
Dyslipidemia		Dyslipidemia		Vaccines
Antifungals		Antifungals		Antifungals
MARCH		JUNE		OCTOBER
Vaccines		Anticoagulants		Anticoagulants
Anticoagulants		Pain		Pain
Pain		Psych		Psych
Cardiovascular		Respiratory		Diabetes
		Cardiovascular		Cardiovascular
APRIL		JULY		NOVEMBER
Chemotherapy		Vaccines		Chemotherapy
Antiemetics		Chemotherapy		Antiemetics
Psych		Antiemetics		Respiratory
Diabetes		Dyslipidemia
Respiratory		Diabetes

 

A Continuing Evolution of Influence in Hospital Patient Care

An exploration of the practical implications of healthcare reform.

Intelligence that meets in the proverbial middle of long and short term hospital cost savings objectives

The industry’s largest, most comprehensive, and detailed audit of hospital formulary decisions and trends.